Bluejay Diagnostics, Inc. Depreciation
Bluejay Diagnostics, Inc. (BJDX) reported Depreciation of $55.96 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-12
- Bluejay Diagnostics, Inc. depreciation for the quarter ending 2026-06-30 was $28.19K, a 58.91% increase year-over-year.
- Bluejay Diagnostics, Inc. depreciation for the quarter ending 2026-03-31 was $27.76K, a 50.88% increase year-over-year.
- Bluejay Diagnostics, Inc. depreciation for the quarter ending 2025-12-31 was $27.41K, a 38.63% increase year-over-year.
- Bluejay Diagnostics, Inc. depreciation for the quarter ending 2025-09-30 was $10.62K, a 39.86% decline year-over-year.
- Bluejay Diagnostics, Inc. depreciation for fiscal 2025 was $74.18K, a 1.90% decline from fiscal 2024.
- Bluejay Diagnostics, Inc. depreciation for fiscal 2024 was $75.62K, a 88.34% decline from fiscal 2023.
- Bluejay Diagnostics, Inc. depreciation for fiscal 2023 was $648.71K, a 314.25% increase from fiscal 2022.
- Bluejay Diagnostics, Inc. depreciation for fiscal 2022 was $156.60K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $55.96K 10-Q · filed 2026-08-12 | $83.37K derived: sum of 3 quarters · filed 2026-08-12 | $94.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $27.76K 10-Q · filed 2026-05-07 | $55.18K derived: sum of 2 quarters · filed 2026-05-07 | $65.80K derived: sum of 3 quarters · filed 2026-05-07 | $83.54K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $27.41K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $38.04K derived: sum of 2 quarters · filed 2026-03-06 | $55.78K derived: sum of 3 quarters · filed 2026-08-12 | $74.18K 10-K · filed 2026-03-06 |
| 2025-09-30 | $10.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $28.37K derived: sum of 2 quarters · filed 2026-08-12 | $46.77K 10-Q · filed 2025-11-07 | $66.54K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $17.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $36.14K 10-Q · filed 2026-08-12 | $55.92K derived: sum of 3 quarters · filed 2026-08-12 | $73.58K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $18.40K 10-Q · filed 2026-05-07 | $38.18K derived: sum of 2 quarters · filed 2026-05-07 | $55.84K derived: sum of 3 quarters · filed 2026-05-07 | $74.31K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $19.77K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $37.44K derived: sum of 2 quarters · filed 2026-03-06 | $55.90K derived: sum of 3 quarters · filed 2026-03-06 | $75.62K 10-K · filed 2026-03-06 |
| 2024-09-30 | $17.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $36.13K derived: sum of 2 quarters · filed 2025-11-07 | $55.84K 10-Q · filed 2025-11-07 | $78.19K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $18.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $38.18K 10-Q · filed 2025-08-07 | $60.52K derived: sum of 3 quarters · filed 2025-08-07 | $313.69K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $19.71K 10-Q · filed 2025-05-13 | $42.06K derived: sum of 2 quarters · filed 2025-05-13 | $295.23K derived: sum of 3 quarters · filed 2025-05-13 | $548.40K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $22.34K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $275.52K derived: sum of 2 quarters · filed 2025-03-31 | $528.69K derived: sum of 3 quarters · filed 2025-03-31 | $648.71K 10-K · filed 2025-03-31 |
| 2023-09-30 | $253.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $506.35K derived: sum of 2 quarters · filed 2024-11-07 | $626.37K 10-Q · filed 2024-11-07 | $657.05K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $253.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $373.19K 10-Q · filed 2024-08-14 | $403.87K derived: sum of 3 quarters · filed 2024-08-14 | $446.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $120.02K 10-Q · filed 2024-05-15 | $150.70K derived: sum of 2 quarters · filed 2024-05-15 | $192.82K derived: sum of 3 quarters · filed 2024-05-15 | $236.64K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $30.68K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $72.81K derived: sum of 2 quarters · filed 2024-03-28 | $116.63K derived: sum of 3 quarters · filed 2024-03-28 | $156.60K 10-K · filed 2024-03-28 |
| 2022-09-30 | $42.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $85.94K derived: sum of 2 quarters · filed 2023-11-09 | $125.92K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $43.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $83.79K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $39.97K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |